Brief: Appili Prepares Canadian Long-Term Care Facilities To Enroll Participants In A Clinical Trial Evaluating Favipiravir

Appili Therapeutics

30/07/2020 13:20

July 30 (Reuters) - Appili Therapeutics Inc  APLI.V :
    * APPILI PREPARES CANADIAN LONG-TERM CARE FACILITIES TO
ENROLL
PARTICIPANTS IN A CLINICAL TRIAL EVALUATING FAVIPIRAVIR AS AN
OUTBREAK CONTROL AGENT AGAINST COVID-19
    * APPILI THERAPEUTICS INC - TRIAL IS EXPECTED TO ULTIMATELY
ENROLL
ABOUT 760 PARTICIPANTS AT 16 LTC FACILITIES

Source text for Eikon:  ID:nBw5rWhdMa 
Further company coverage:  APLI.V 

 ((Reuters.Briefs@thomsonreuters.com;))